Onderneming Claris Lifesciences Ltd Bombay S.E.
Aandelen
CLAI
INE562G01018
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 44 | 19-02-01 | |
Director of Finance/CFO | 50 | 01-04-99 | |
Hitesh Shukla
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-10 |
Compliance Officer | - | - | |
Director/Board Member | - | 01-05-00 | |
Mit Desai
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 44 | 19-02-01 | |
Director/Board Member | 39 | 13-06-06 | |
Chairman | 87 | 26-09-08 | |
Director of Finance/CFO | 50 | 01-04-99 | |
Director/Board Member | - | 01-05-00 | |
Anup Pravin Shah
BRD | Director/Board Member | 47 | 23-02-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 567 765 | 1 ( 0,000002 %) | 0 | 0,000002 % |
Bedrijfsgegevens
Claris Lifesciences Ltd.
Near Parimal Railway Crossing Ellisbridge
380006, Ahmedabad
+
http://www.clarislifesciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,59% | 44,15 mld. | |
+23,03% | 23,02 mld. | |
+18,81% | 15,33 mld. | |
+12,26% | 13,74 mld. | |
+52,55% | 12,16 mld. | |
-10,02% | 6,84 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,88% | 5,66 mld. |
- Beurs
- Aandelen
- Koers CLAI
- Koers CLAI
- Onderneming Claris Lifesciences Ltd